JUL 29, 2026 · JOURNAL ARTICLE
1-Deoxynojirimycin attenuates diabetic cardiomyopathy via PI3K/AKT-mediated mitochondrial protection and anti-apoptosis.
Journal of Ethnopharmacology
Early mechanistic study combining in vitro and animal models with pathway inhibitor validation, but lacking human clinical data and using surrogate endpoints of cardiac function and cell viability.
Study details
DesignIn vitro cell culture study combined with d…
Intervention1-Deoxynojirimycin (DNJ), a naturally occur…
ComparatorHigh-glucose conditions in H9C2 cells witho…